Ocugen seeks USFDA nod for phase 3 trials of Covaxin

We are very excited to take this next step in the development of COVAXIN: Ocugen CEO

Comments

Popular posts from this blog

BJP’s victory in local body polls indicator of coming Assembly polls: Bommai

Should there be a lesson on Jinnah?: Karnataka K.S. Eshwarappa asks

Bengaluru: Bus conductor fails to return Rs 1; court orders BMTC to pay Rs 3K as compensation